Compounds > rosiglitazone
Page last updated: 2024-08-25

rosiglitazone and thyroxine

rosiglitazone has been researched along with thyroxine in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's5 (62.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Arifi, S; Bischoff, I; Chaikuad, A; Fürst, R; Gellrich, L; Goebel, T; Heering, J; Heitel, P; Kahnt, A; Kilu, W; Knapp, S; Merk, D; Paulke, A; Pogoda, W; Pollinger, J; Proschak, E; Schubert-Zsilavecz, M; Steinhilber, D; Wurglics, M1
Ardecky, RJ; Boehm, MF; Chen, JH; D'Arrigo, J; Grese, TA; Karanewsky, DS; Leibowitz, MD; Liu, S; Mais, DA; Mapes, CM; Michellys, PY; Montrose-Rafizadeh, C; Ogilvie, KM; Reifel-Miller, A; Rungta, D; Thompson, AW; Tyhonas, JS1
Jatwa, R; Kar, A; Panda, S; Parmar, HS1
Clerget-Froidevaux, MS; Decherf, S; Demeneix, B; Elgaaied, AB; Guissouma, H; Kouidhi, S; Seugnet, I1
Blanchard, PG; Deshaies, Y; Festuccia, WT; Magdalon, J; Oliveira, TB; Paschoal, VA; Richard, D1

Reviews

1 review(s) available for rosiglitazone and thyroxine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

7 other study(ies) available for rosiglitazone and thyroxine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
l-Thyroxin and the Nonclassical Thyroid Hormone TETRAC Are Potent Activators of PPARγ.
    Journal of medicinal chemistry, 2020, 07-09, Volume: 63, Issue:13

    Topics: Amino Acid Sequence; Animals; Drug Evaluation, Preclinical; Male; Mice; Models, Molecular; PPAR gamma; Protein Conformation; Thyroxine

2020
Design, synthesis, and structure-activity relationship studies of novel 6,7-locked-[7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta]-2,4,6-trienoic acids.
    Journal of medicinal chemistry, 2003, Sep-11, Volume: 46, Issue:19

    Topics: Alkenes; Animals; Benzene Derivatives; Caprylates; Cell Line; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Design; Drug Synergism; Hypoglycemic Agents; Male; Mice; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Retinoic Acid; Retinoid X Receptors; Rosiglitazone; Structure-Activity Relationship; Thiazoles; Thiazolidinediones; Thyroxine; Transcription Factors; Transfection; Triglycerides

2003
Amelioration of corticosteroid-induced type 2 diabetes mellitus by rosiglitazone is possibly mediated through stimulation of thyroid function and inhibition of tissue lipid peroxidation in mice.
    Basic & clinical pharmacology & toxicology, 2007, Volume: 101, Issue:3

    Topics: Animals; Blood Glucose; Catalase; Cholesterol; Dexamethasone; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glutathione; Hypoglycemic Agents; Insulin; Kidney; Lipid Peroxidation; Male; Mice; Myocardium; Rosiglitazone; Superoxide Dismutase; Thiazolidinediones; Thyroxine; Triglycerides; Triiodothyronine

2007
Peroxisome proliferator-activated receptor-gamma (PPARgamma) modulates hypothalamic Trh regulation in vivo.
    Molecular and cellular endocrinology, 2010, Apr-12, Volume: 317, Issue:1-2

    Topics: Anilides; Animals; Animals, Newborn; Gene Expression Regulation; Gene Knockdown Techniques; Glucose Transporter Type 4; Hypothalamus; Injections, Intraventricular; Mice; Pioglitazone; PPAR gamma; Promoter Regions, Genetic; Retinoid X Receptor alpha; Rosiglitazone; Thiazolidinediones; Thyroid Hormone Receptors beta; Thyrotropin-Releasing Hormone; Thyroxine; Transfection; Triiodothyronine

2010
PPARγ activation attenuates cold-induced upregulation of thyroid status and brown adipose tissue PGC-1α and D2.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2012, Dec-15, Volume: 303, Issue:12

    Topics: Adipose Tissue, Brown; Animals; Cold Temperature; Iodide Peroxidase; Iodothyronine Deiodinase Type II; Male; Models, Animal; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Rats; Rats, Sprague-Dawley; RNA-Binding Proteins; Rosiglitazone; Signal Transduction; Thiazolidinediones; Thyroid Gland; Thyroxine; Time Factors; Transcription Factors; Triiodothyronine; Up-Regulation

2012